Authors
    • Interventional Cardiology
    • Interventional Cardiology
    Professor of Medicine at Columbia University and Interventional Cardiologist and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York Presbyterian Hospital/Columbia University Medical Center
    Professor of Medicine at Columbia University and Interventional Cardiologist and Director of Cardiovascular Research and...
    • Director of Cardiovascular Research and Education, Center for Interventional Vascular Therapy at New York-Presbyterian Hospital
    Gregg W. Stone, MD, FACC, FSCAI is Professor of Medicine at the Columbia University Medical Center, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at New York-Presbyterian Hospital, and Co-Director of Medical Research and Education at the Cardiovascular Research Foundation in New York, NY. Dr. Stone has served as the national or international principal investigator for approximately 100 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature as well as numerous book chapters, and has delivered thousands of invited lectures around the world. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter mitral valve repair and replacement; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; new device angioplasty including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; left atrial appendage closure; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone, along with Dr. Martin B. Leon, is the director of Transcatheter Cardiovascular Therapeutics (TCT), the world's largest symposium devoted to interventional cardiology and vascular medicine, founded the annual National Interventional Cardiology Fellow's Course, and co-directs multiple other courses, including Optimizing Complex PCI Outcomes, The Chronic Total Occlusion Summit, The Left Main Summit, Bioresorbable Scaffolds: A Breakthrough PCI Technology, LAA Occlusion: A Technique Oriented Course, and Transcatheter Valve Therapies (TVT). Dr. Stone is also a director or co-director of numerous annual international courses including CIT (China Interventional Therapeutics in Beijing, China), TCTAP (TCT Asia Pacific in Seoul, S. Korea), JIM (Joint Interventional Course in Italy), and TCT Russia (in Moscow). Dr. Stone's medical practice is devoted to Interventional Cardiology at New York-Presbyterian Hospital and Columbia University Medical Center. Dr. Stone previously held similar positions at Lenox Hill Hospital in New York and the Washington Hospital Center in Washington, DC. Previously he was the Director of Interventional Cardiology at the Cardiovascular Institute at El Camino Hospital and Stanford University Medical Center in California. Dr. Stone completed medical school at Johns Hopkins University Medical Center, in Baltimore, MD, and his internship and residency at the New York Hospital-Cornell Medical Center in New York City. He completed his general cardiology fellowship at Cedars-Sinai Medical Center in Los Angeles, CA, under Dr. Jeremy Swan, and subsequently a dedicated fellowship in advanced coronary angioplasty with Dr. Geoffrey O. Hartzler in Kansas City, MO.
    • Interventional Cardiology
    • Radiology
    • Medical Director at The Christ Hospital Heart and Vascular Center
    Dean J. Kereiakes, M.D., FACC, FSCAI is Medical Director of The Christ Hospital Heart and Vascular Center, Medical Director of the Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, and Professor of Clinical Medicine at Ohio State University. Dr. Kereiakes received his medical degree and was valedictorian of his graduating class at the University of Cincinnati in Ohio. His postgraduate training included internship and residency at the University of California, San Francisco, a senior residency at Massachusetts General Hospital in Boston, and a chief residency at the University of California, San Francisco. He then completed fellowships in adult cardiology at the University of California, San Francisco and in coronary angioplasty at the San Francisco Heart Institute and the Sequoia Hospital. Dr. Kereiakes has been an original investigator for most of the interventional technologies introduced in the last two decades and has performed more than30,000 catheterization laboratory procedures. In addition to lecturing nationally and internationally, Dr. Kereiakes is very active as a clinical and scientific investigator and has participated in over 1300 clinical research protocols. He has published over 800 journal articles, abstracts and book chapters. He has served on the editorial boards of Circulation, The Journal of the American College of Cardiology (JACC), Journal of the American College of Cardiology Cardiovascular Interventions, The American Heart Journal, Journal of Invasive Cardiology and The American Journal of Cardiology and The Journal of Interventional Cardiology, as well as being a Section Editor for MedReviews (New Drugs and Devices). He was previously a Section Editor for Circulation and received the Simon Dack Award for Outstanding Scholarship from JACC in 2011. Dr. Kereiakes is a Fellow of the American College of Cardiology as well as The Society for Cardiovascular Angiography and Interventions. Dr. Kereiakes has been selected as Outstanding Alumnus University of Cincinnati School of Medicine, Who’s Who in the World, Who’s Who in America, Who’s Who in Medicine and Healthcare, Who’s Who in Science and Engineering, Best Doctors in America and has received the Cincinnati Business Courier Health Care Hero - Innovator award and the Ohio Valley American Heart Association’s Kaplan Visionary Award for cardiovascular research. He was honored with an Honorary Doctorate of Sciences from the University of Cincinnati in 2014.
    • Interventional Cardiology
    • Director Of Interventional Cardiology, Senior Academic Officer at Cleveland Clinic Lerner College of Medicine
    Stephen Ellis, M.D. is the Director of Interventional Cardiology, Senior Academic Officer and Professor of Medicine at the Cleveland Clinic. He received his M.D. degree from the University of California Los Angeles and received subsequent training at Cedars Sinai, Los Angeles, The Brigham and Women’s Hospital, Stanford University and Emory University. He is a practicing interventional cardiologist specializing in the treatment of complex or high-risk patients, genetics and clinical trials. He has served as National Principal Investigator for several key randomized trials, including RESCUE I, GUSTO IIB PTCA, TAXUS IV/V and ABSORB III. As of 2015 Dr. Ellis has authored over 900 papers or abstracts, edited three textbooks of interventional cardiology, and is widely considered to be an international authority on coronary stents, the assessment of outcomes after intervention, and novel therapeutic approaches to coronary artery disease and chronic heart failure.